Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping
NCT ID: NCT07200778
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
66 participants
INTERVENTIONAL
2025-09-11
2026-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methods Decreasing Bleeding in Open Myomectomy
NCT05806307
Different Methods to Minimize Blood Loss During Laparoscopic Myomectomy; A Randomized Controlled Clinical Trial
NCT06566352
Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy.
NCT03892668
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
NCT06325501
Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.
NCT04694677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
participants will undergo umbilico-uterine trunk occlusion
umbilico-uterine trunk occlusion
participants will undergo umbilico-uterine trunk occlusion during laparoscopic myomectomy
Group B
participants will undergo local injections of epinephrine into the serosal and/or myometrium, covering the myoma before the uterine incision
local epinephrine infiltration
participants will undergo local injections of epinephrine into the serosal and/or myometrium, covering the myoma before the uterine incision during laparoscopic myomectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
umbilico-uterine trunk occlusion
participants will undergo umbilico-uterine trunk occlusion during laparoscopic myomectomy
local epinephrine infiltration
participants will undergo local injections of epinephrine into the serosal and/or myometrium, covering the myoma before the uterine incision during laparoscopic myomectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptoms of menorrhagia, pelvic pain, or infertility
* Plan to have a laparoscopic myomectomy
* Number of myomas ≤ 4, with the largest myoma measuring ≤ 9 cm
Exclusion Criteria
* Dominant pedunculated subserosal FIGO classification (6-7)
* Submucosal type of myoma FIGO classification (0-2)
* Suspicion of malignant uterine or adnexal diseases
* Major medical comorbidities or psychiatric illnesses that could affect follow-up and/or compliance
* Refusal to participate or provide consent to the procedures.
19 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Hassan Mohamed Abdel Ghfar
Lecturer of Obstetrics and Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia advanced laparoscopy unit
Minya, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohamed abdelghfar, Lecturer
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1531-5-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.